Clinical Trial

IR-MED’s Key Clinical and Media Milestones

PressureSafe(TM) clinical results presented to global nursing leaders; the Company engages with U.S. investment community and national media in parallel…

2 months ago

Electronic Trial Master File (eTMF) Systems Market worth $2.49 billion by 2030 with 12.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 27, 2025 /PRNewswire/ -- The global Electronic Trial Master File (eTMF) Systems Market, valued at US$1.21 billion…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

Stemtech Corporation – Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell…

2 months ago

Stemtech Corporation – Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell…

2 months ago

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical…

2 months ago

Stemtech Corporation – Stemtech Healthsciences India Pvt Ltd Announces Strategy for Market Entry

NAPLES, FL / ACCESS Newswire / October 27, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell…

2 months ago

Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial

Orchestra BioMed’s Virtue® Sirolimus AngioInfusionTM Balloon (“Virtue SAB”) is the first non-coated drug-eluting balloon system designed to deliver a large…

2 months ago